No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ALLR Allarity Therapeutics
- 0.9901
- -0.0399-3.87%
Close Dec 20 16:00 ET
- 1.0097
- +0.0196+1.98%
Post 20:01 ET
4.39MMarket Cap-0.14P/E (TTM)
1.0200High0.9100Low551.12KVolume1.0000Open1.0300Pre Close545.47KTurnover12.43%Turnover Ratio0.00P/E (Static)4.43MShares342.000052wk High0.34P/B4.39MFloat Cap0.900052wk Low--Dividend TTM4.43MShs Float15288000.0000Historical High--Div YieldTTM10.68%Amplitude0.9000Historical Low0.9890Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Allarity Therapeutics Inc - Two Patients Exceed 14 Months on Treatment in Phase 2 Trial
Express News | Allarity Therapeutics Inc - Maintains Cash Balance of $18.5 Million
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Allarity Therapeutics | 10-Q: Q3 2024 Earnings Report
Allarity Therapeutics Q3 EPS $(7.71) Beats $(8.40) Estimate
Allarity Therapeutics | 8-K: Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Heat List
US
Overall
Symbol
Price
% Chg
No Data